Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Nvidia Stock Falls In Sympathy With Micron As Economic Woes Hamper Chip Demand: What's Next?

Nvidia Corporation (NASDAQ: NVDA) reached a new 52-week low on Friday, despite the S&P 500 trading slightly higher.

Benzinga

U.S. Stocks Turn Lower; Dow Tumbles Over 100 Points

U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 100 points on Friday.

Benzinga

Piper Sandler Maintains Neutral Rating for MarketAxess Holdings: Here's What You Need To Know

Piper Sandler has decided to maintain its Neutral rating of MarketAxess Holdings (NASDAQ:MKTX) and lower its price target from $300.00 to $285.00. Shares of MarketAxess Holdings are trading down 0.69% over the last 24 hours, at $254.25 per share.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Looking At ASML Holding's Recent Whale Trades

Someone with a lot of money to spend has taken a bullish stance on ASML Holding (NASDAQ:ASML). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

JP Morgan Maintains Overweight Rating for Pinnacle Finl Partners: Here's What You Need To Know

JP Morgan has decided to maintain its Overweight rating of Pinnacle Finl Partners (NASDAQ:PNFP) and lower its price target from $123.00 to $95.00. Shares of Pinnacle Finl Partners are trading up 0.25% over the last 24 hours, at $72.49 per share.

Benzinga

Expert Ratings for Zions Bancorp

Analysts have provided the following ratings for Zions Bancorp (NASDAQ:ZION) within the last quarter:

Benzinga

HC Wainwright & Co. Maintains Buy Rating for Celldex Therapeutics: Here's What You Need To Know

HC Wainwright & Co. has decided to maintain its Buy rating of Celldex Therapeutics (NASDAQ:CLDX) and raise its price target from $60.00 to $73.00. Shares of Celldex Therapeutics are trading down 14.91% over the last 24 hours, at $22.94 per share.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.

Benzinga

Why Borqs Technologies Shares Are Gaining Today

Borqs Technologies, Inc's (NASDAQ:BRQS) solar energy storage systems subsidiary, Holu Hou Energy LLC (HHE), collaborated with developers and property owners for nine solar plus energy storage projects in the State of Hawaii totaling $49.8 million, as of the last day of Q2, 2022. Eight of the nine projects were on the island of…

Benzinga

Apple, Microsoft, Disney And American Express Continue To Plummet: Dow Jones Index Has Worst First Half In Decades

The U.S. Stock Market has had a rough 2022 so far and the SPDR Dow Jones Industrial Average ETF Trust (NYSEARCA: DIA) has been no exception to that. Since the start of the calendar year, the index has lost close to 6,000 points as inflation continues to rise and consumer spending falls.

Benzinga

Analyst Ratings for Enanta Pharmaceuticals

Within the last quarter, Enanta Pharmaceuticals (NASDAQ:ENTA) has observed the following analyst ratings:

Benzinga

Advanced Micro Devices Whale Trades For July 01

A whale with a lot of money to spend has taken a noticeably bearish stance on Advanced Micro Devices. Looking at options history for Advanced Micro Devices (NASDAQ:AMD) we detected 18 strange trades.

Benzinga

Analyst Ratings for Tradeweb Markets

Analysts have provided the following ratings for Tradeweb Markets (NASDAQ:TW) within the last quarter:

Benzinga

Blizzard Entertainment Acquires This Boston-Based Studio For Undisclosed Terms

Activision Blizzard, Inc's (NASDAQ:ATVI) Blizzard Entertainment closed the acquisition of the Boston-based studio Proletariat. The financial terms of the transaction remain undisclosed. The acquisition will help better serve players in the multiplayer online role-playing game World of Warcraft. "Over the next two years, we plan to hire hundreds of the best developers to…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

A Bullish Sign Appears On Grifols's Chart

If history is any guide, there may be good fortune ahead for shares of Grifols (NASDAQ:GRFS). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga

Ingles Markets: Dividend Insights

Tuesday marks the last chance for investors to receive the next dividend payout from Ingles Markets (NASDAQ:IMKTA).

Benzinga

5 Value Stocks To Watch In The Consumer Defensive Sector

Understanding Value Stocks

Benzinga

BofA Says Canopy Stock Is 'A Show Me Story,' Lowers Price Target

Canopy Growth Corporation (NASDAQ: CGC)

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Labor Market Is Tight Yet Layoffs Surge As Tesla, Coinbase, Netflix And Others Cut Staff

The recent unemployment claims numbers confirm the Federal Reserve's assertion that the labor market is tight. However, layoffs are intensifying, particularly in the tech and cryptocurrency sectors.

Benzinga

$1000 Invested In Palo Alto Networks 10 Years Ago Would Be Worth This Much Today

Palo Alto Networks (NASDAQ:PANW) has outperformed the market over the past 10 years by 14.52% on an annualized basis producing an average annual return of 25.16%. Currently, Palo Alto Networks has a market capitalization of $49.95 billion.

Benzinga

Expert Ratings for Huntington Bancshares

Within the last quarter, Huntington Bancshares (NASDAQ:HBAN) has observed the following analyst ratings:

Benzinga

Netflix Crashes As 'Stranger Things 4' Volume 2 Goes Live: Was Vecna To Blame?

Talk about bad timing: Netflix (NASDAQ: NFLX) crashed earlier this morning shortly after the final two episodes of its hit series "Stranger Things 4" went live.

Benzinga

What 6 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical

Analysts have provided the following ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) within the last quarter:

Benzinga

Here's How Much $100 Invested In O'Reilly Automotive 15 Years Ago Would Be Worth Today

O'Reilly Automotive (NASDAQ:ORLY) has outperformed the market over the past 15 years by 14.76% on an annualized basis producing an average annual return of 20.97%. Currently, O'Reilly Automotive has a market capitalization of $41.50 billion.

Benzinga

Where Pinnacle Finl Partners Stands With Analysts

Analysts have provided the following ratings for Pinnacle Finl Partners (NASDAQ:PNFP) within the last quarter:

1 … 402 403 404 405

People

Bobby Kotick

102 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.